Garwood Medical Devices, LLC (GMD), founded July 15, 2014, is a medical device company developing a new class of active, remotely powered medical devices. They are clinician programmable, providing treatment while remotely monitoring operating parameters, patient biometrics and compliance. GMD addresses several expensive ($20B+) and complex, frequently devastating health issues, providing effective, efficient treatments for chronic wound healing, bone growth and peri-prosthetic infection while freeing the patient from a power cord and the need for implanted batteries. Our lean organization leverages our (GMD and exclusively licensed University at Buffalo) IP portfolio by harnessing UB physical assets, and critically, our UB development team, led by Professor Ed Furlani. Previously 28 years as Kodak Senior Principal Scientist, before transitioning to UB, he has degrees in Electrical Engineering & Theoretical Physics, and over 150 patents. His varied interests include lasers, photonics and bio-photonics. Dr. Furlani leads the team of six brilliant professors in complimentary disciplines: Physics, Chemical, Biological, Electrical, Biomedical & Computer Engineering, Microbiology & Immunology. Three of the six are inventors of technologies we license from UB. Financial viability is important: •GMD has been accepted into StartUp NY, which has numerous benefits, including: NYS income tax exemption for the company, investors and employees, sales tax exemption for 10 years, office space on the medical campus at low rates, and other benefits. •The NYS Buffalo Institute for Genomics and Data Analytics has agreed to make a significant four-year investment in Garwood. •GMD is close to completing its $3.6MM Series A round.